tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

AIM ImmunoTech Inc

AIM
Add to Watchlist
0.257USD
+0.022+9.45%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.12MMarket Cap
LossP/E TTM

AIM ImmunoTech Inc

0.257
+0.022+9.45%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

AIM Financials

See AIM ImmunoTech Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

AIM ImmunoTech Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.69/-0.37
Revenue / Forecast
22.00K/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
88.00K
-48.24%
EPS(YoY)
-8.61
72.14%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
86.81%-0.69
84.51%-1.44
75.57%-1.57
-5.89%-3.68
55.21%-5.27
63.76%-9.32
60.08%-6.42
65.73%-3.48
-55.49%-11.76
-181.77%-25.72
---16.07
---10.14
---7.56
---9.13
---0.31
----
----
----
----
----
Revenue
37.50%22.00K
-53.33%21.00K
-25.71%26.00K
-50.00%25.00K
-60.00%16.00K
-30.77%45.00K
-23.91%35.00K
19.05%50.00K
-18.37%40.00K
16.07%65.00K
119.05%46.00K
40.00%42.00K
48.48%49.00K
12.00%56.00K
-36.36%21.00K
30.43%30.00K
17.86%33.00K
19.05%50.00K
-8.33%33.00K
-42.50%23.00K
Net Profit
18.41%-3.02M
30.03%-4.17M
11.24%-3.28M
-52.18%-2.79M
36.31%-3.71M
52.55%-5.97M
52.66%-3.70M
62.60%-1.84M
-58.89%-5.82M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
24.92%-4.39M
-66.88%-6.38M
17.44%-4.85M
-6.73%-3.82M
-48.60%-5.85M
-15.73%-3.83M
-74.36%-5.88M
Net Margin
40.66%-13740.91%
-49.93%-19880.95%
-19.48%-12630.77%
-204.36%-11176.00%
-59.23%-23156.25%
31.46%-13260.00%
37.78%-10571.43%
68.58%-3672.00%
-94.64%-14542.50%
-146.86%-19347.69%
---16991.30%
---11688.10%
---7471.43%
---7837.50%
---17712.94%
----
----
----
----
----
Gross Margin
118.18%81.82%
-207.14%-90.48%
-309.40%-161.54%
-28.57%60.00%
-53.13%37.50%
3.56%84.44%
121.79%77.14%
-16.00%84.00%
-20.00%80.00%
-18.46%81.54%
--34.78%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
57.28%49.09%
188.85%77.41%
70.19%34.22%
230.52%55.46%
96.37%31.21%
--26.80%
--20.11%
--16.78%
--15.89%
----
----
----
----
----
--0.00%
----
----
----
----
----
Income Statement
Revenue
37.50%22.00K
-53.33%21.00K
-25.71%26.00K
-50.00%25.00K
-60.00%16.00K
-30.77%45.00K
-23.91%35.00K
19.05%50.00K
-18.37%40.00K
16.07%65.00K
119.05%46.00K
40.00%42.00K
48.48%49.00K
12.00%56.00K
-36.36%21.00K
30.43%30.00K
17.86%33.00K
19.05%50.00K
-8.33%33.00K
-42.50%23.00K
Operating profit
38.49%-2.23M
49.58%-2.95M
45.49%-2.45M
28.37%-2.65M
36.89%-3.62M
58.19%-5.86M
44.97%-4.49M
32.36%-3.69M
-33.50%-5.73M
-152.05%-14.00M
-25.09%-8.16M
-16.32%-5.46M
-36.26%-4.29M
1.94%-5.56M
-65.97%-6.52M
-26.28%-4.70M
15.83%-3.15M
-12.98%-5.67M
-17.11%-3.93M
-11.32%-3.72M
Net Profit
18.41%-3.02M
30.03%-4.17M
11.24%-3.28M
-52.18%-2.79M
36.31%-3.71M
52.55%-5.97M
52.66%-3.70M
62.60%-1.84M
-58.89%-5.82M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
24.92%-4.39M
-66.88%-6.38M
17.44%-4.85M
-6.73%-3.82M
-48.60%-5.85M
-15.73%-3.83M
-74.36%-5.88M
Balance Sheet
Current assets
140.48%6.21M
-21.10%3.29M
-65.98%2.58M
-90.11%1.02M
-77.14%2.58M
-71.31%4.18M
-66.71%7.57M
-64.11%10.36M
-65.90%11.31M
-59.92%14.56M
-44.73%22.74M
-37.30%28.87M
-34.18%33.16M
-27.67%36.32M
8.18%41.15M
11.42%46.05M
-1.64%50.38M
24.57%50.21M
-4.33%38.04M
17.52%41.33M
Total current liabilities
-37.08%6.14M
-34.72%6.22M
-59.97%4.04M
17.54%10.39M
-1.10%9.77M
10.21%9.54M
114.16%10.10M
206.48%8.84M
437.62%9.88M
535.71%8.65M
62.90%4.72M
110.89%2.88M
139.82%1.84M
102.23%1.36M
277.44%2.90M
56.16%1.37M
-21.03%766.00K
-38.93%673.00K
-3.52%767.00K
5.16%876.00K
Total assets
37.40%8.59M
-32.83%5.78M
-59.57%5.49M
-73.73%4.13M
-61.41%6.25M
-55.59%8.61M
-51.23%13.59M
-53.25%15.71M
-56.79%16.19M
-52.13%19.38M
-39.81%27.86M
-33.93%33.62M
-30.82%37.46M
-29.83%40.49M
-26.62%46.28M
-23.74%50.88M
-26.91%54.16M
-10.66%57.70M
-1.69%63.08M
33.12%66.72M
Total liabilities
-36.07%6.46M
56.75%15.56M
8.38%11.57M
11.05%10.68M
-11.07%10.11M
8.56%9.93M
103.00%10.68M
176.08%9.61M
359.48%11.36M
352.82%9.15M
46.49%5.26M
65.49%3.48M
189.58%2.47M
146.34%2.02M
247.53%3.59M
76.81%2.10M
-72.65%854.00K
-75.08%820.00K
-66.15%1.03M
-61.99%1.19M
Total equity
155.09%2.13M
-640.02%-9.78M
-308.69%-6.08M
-207.28%-6.55M
-179.92%-3.86M
-112.92%-1.32M
-87.12%2.91M
-79.75%6.10M
-86.21%4.83M
-73.40%10.23M
-47.06%22.60M
-38.22%30.14M
-34.36%34.99M
-32.37%38.47M
-31.19%42.70M
-25.56%48.78M
-24.89%53.30M
-7.20%56.88M
1.53%62.05M
39.45%65.53M
Cash Flow Statement
Net operating income
-15.16%-2.72M
49.79%-1.99M
-63.31%-5.08M
49.10%-1.53M
50.97%-2.36M
59.47%-3.96M
45.16%-3.11M
-39.39%-3.01M
-30.84%-4.81M
-60.78%-9.76M
-14.15%-5.67M
6.70%-2.16M
-33.43%-3.68M
-5.64%-6.07M
-43.71%-4.97M
-34.63%-2.31M
9.43%-2.76M
-101.30%-5.75M
-15.66%-3.46M
-17.27%-1.72M
Net investment
-104.12%-37.00K
-102.56%-95.00K
-11.38%296.00K
-8.72%754.00K
668.35%898.00K
1830.84%3.70M
199.40%334.00K
504.90%826.00K
-102.56%-158.00K
-106.36%-214.00K
-234.40%-336.00K
-102.64%-204.00K
77.46%-78.00K
823.90%3.36M
168.31%250.00K
770.23%7.72M
-166.16%-346.00K
300.00%364.00K
96.18%-366.00K
60.17%-1.15M
Net financing
746.52%5.59M
162.20%2.72M
4756.93%6.65M
-85.46%355.00K
-76.67%660.00K
605.44%1.04M
-41.20%137.00K
48720.00%2.44M
2729.00%2.83M
--147.00K
832.00%233.00K
-90.91%5.00K
--100.00K
-100.00%0.00
-16.67%25.00K
101.16%55.00K
-100.00%0.00
-95.89%125.00K
-99.83%30.00K
-144.60%-4.76M

FAQs

What is the total revenue of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its total revenue reached 88.00K, with a year-on-year change of 170.00K.

What are the current assets of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its current assets were 3.29M, with a year-on-year change of -21.10.

What are the total assets of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its total assets of AIM ImmunoTech Inc were 5.78M, with a year-on-year change of -32.83.

What are the total liabilities of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its total liabilities of AIM ImmunoTech Inc were 15.56M, with a year-on-year change of 56.75.

What is the total equity of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its total equity of AIM ImmunoTech Inc was -9.78M, with a year-on-year change of -640.02.

What is the net operating income of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its net operating income of AIM ImmunoTech Inc was -11.66M, with a year-on-year change of 41.01.

What is the net investment of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its net investment of AIM ImmunoTech Inc was 1.85M, with a year-on-year change of -60.62.

What is the net financing of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its net financing of AIM ImmunoTech Inc was 10.39M, with a year-on-year change of 61.20.

What is the Earnings Per Share (EPS) of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.61, with a year-on-year change of 72.14.

What is the net income of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its net income was -13.96M, with a year-on-year change of 19.41.

What is the net margin of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its net profit margin was -15861.36, with a year-on-year change of -55.68.

What is the gross margin of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its gross margin was -45.45, with a year-on-year change of -155.59.

What is the debt-to-asset ratio of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its debt-to-asset ratio was 77.41, with a year-on-year change of 188.85.

What is the Return on Assets (ROA) of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its Return on Assets (ROA) was -194.00, with a year-on-year change of -56.75.

What is the operating profit of AIM ImmunoTech Inc?

According to AIM ImmunoTech Inc's FY2025 earnings report, its operating profit was -11.66M, with a year-on-year change of 41.01.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy